Fol. Biol. 2006, 52, 6-9
https://doi.org/10.14712/fb2006052010006
Apoptosis of Cardiomyocytes in Myocarditis
References
1. 2001) Apoptosis in myocarditis and dilated cardiomyopathy: does entorovirus genome persistence protect from apoptosis? An endomyocardial biopsy study. Cardiovasc. Pathol. 10, 229-234.
< , P., Jobmann, M., Meye, E., Punkuweit, S., Maisch, B. (https://doi.org/10.1016/S1054-8807(01)00077-1>
2. 1987) Acute myocarditis: a diagnostic dilemma. Br. Heart J. 58, 6-8.
< , M. (https://doi.org/10.1136/hrt.58.1.6>
3. Braunwald, E. (1997) Heart failure. In: Harrison’s Principles of Internal Medicine, 14th edition, eds. Isselbacher K. J., Braunwald E., Wilson J. D., Martin J. B., Fauci A. S., Kasper D. L., pp. 1105-1135, McGraw-Hill, New York, St. Louis, London.
4. 1998) Expression of apoptosis related proteins in experimental viral myocarditis. Cardiovasc. Res. 38, 158-168.
< , J. T., Chandrasekar, B., Freeman, G. L. (https://doi.org/10.1016/S0008-6363(97)00323-4>
5. 1998) A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391, 43-50.
< , M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., Nagata, S. (https://doi.org/10.1038/34112>
6. 1984) Role of cardiac biopsy in the diagnosis and management of cardiac disease. Prog. Cardiovasc. Dis. 27, 153-172.
< , R. E., Mason, J. W. (https://doi.org/10.1016/0033-0620(84)90002-1>
7. 1998) Contractile depression and expression of proinflammatory cytokines and inducible nitric oxide synthase in viral myocarditis. Am. J. Physiol. 274, H249-H258.
< , G. L., Colston, J. T., Zabalgoitia, M., Chandrasekar, B. (https://doi.org/10.1152/ajpcell.1998.274.1.C282>
8. 2000) Predictors of disease course in patients with acute myocarditis. Circulation 102, 2829-2835.
< , K., Kodama, M., Okura, Y. (https://doi.org/10.1161/01.CIR.102.23.2829>
9. 2002) Improved detection of apoptotic cells in archival paraffin sections: immunohistochemistry using antibodies to cleaved caspase 3. J. Histochem. Cytochem. 50, 449-454.
< , A. M., Willingham, MC. (https://doi.org/10.1177/002215540205000401>
10. 1994) Apoptosis in acute and chronic myocarditis. Jpn. Heart J. 35, 745-750.
< , H., Okada, R., Kawano, Y., Sueyoshi, N., Shirai, T. (https://doi.org/10.1536/ihj.35.745>
11. 2004) Apoptotic cardiomyocyte death in fatal myocarditis. Am. J. Cardiol. 94, 746-750.
< , V., Saraste, A., Saukko, P., Henn, V., Pulkki, K., Vuorinen, T., Voipio-Pulkki, L. M. (https://doi.org/10.1016/j.amjcard.2004.05.056>
12. 2005) Diagnosis and presentation of fatal myocarditis. Hum. Pathol. 36, 1003-1007.
< , V., Saukko, P., Lignitz, E., Schwesinger, G., Henn, V., Saraste, A., Voipio-Pulkki, L. M. (https://doi.org/10.1016/j.humpath.2005.07.009>
13. 1994) Identification of a p53-dependent negative response element in the Bcl-2 gene. Cancer Res. 54, 3131-3135.
, T., Harigai, M., Hanada, M., Reed, J. C. (
14. 1997) Apoptosis in the failing human heart. N. Engl. J. Med. 336, 1131-1141.
< , G., Abbi, R., Quaini, F., Kajstura, J., Cheng, W., Nitahara, J.A., Quaini, E., Di Loreto, C., Beltrami, C. A., Krajewski, S., Reed, J. C., Anversa, P. (https://doi.org/10.1056/NEJM199704173361603>
15. 2000) Apoptosis and proliferation of myocytes in heart failure of different etiologies. Cardiovasc. Pathol. 9, 149-152.
< , D., Zorc-Pleskovič, R., Zorc, M. (https://doi.org/10.1016/S1054-8807(00)00032-6>
16. 1994) Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124, 1-6.
< , J. C. (https://doi.org/10.1083/jcb.124.1.1>
17. 1993) Phagocytic recognition of cells undergoing apoptosis. Immunol. Today 14, 131-136.
< , J., Fodok, V., Henson, P., Haslett, C. (https://doi.org/10.1016/0167-5699(93)90215-7>
18. 1996) Lymphocyte apoptosis induced by CD95 (apoA1/Fas) ligand-expressing tumor cells – a mechanism of immune evasion? Nat. Med. 2, 1361-1366.
< , S., Hofmann, W. J., Hug, H., Muller, M., Otto, G., Strand, D., Mariani, S. M., Stremmel, W., Krammer, P. H., Galle, P. R. (https://doi.org/10.1038/nm1296-1361>
19. 1980) Viral myocarditis: a review. Am. J. Pathol. 101, 425-466.
, J. F. (
20. 2003) Apoptosis of myocytes and proliferation markers as prognostic factors in end-stage dilated cardiomyopathy. Cardiovasc. Pathol. 12, 36-39.
< , M., Vraspir-Porenta, O., Zorc-Pleskovic, R., Radovanovic, N., Petrovic, D. (https://doi.org/10.1016/S1054-8807(02)00134-5>